What records are connected here?
- Evidence lanes
- 1
- Source years
- 14
- Drugs@FDA applications
- 0
These are counts in PeptideScanner’s selected public collection, not measures of research quality, medical relevance, safety, or effectiveness.
Not FDA-approved2,3Evidence: Animal and lab onlyMuscle
Also called Mechano growth factor pegylated, Mechano growth factor1,2
PEG-MGF is a pegylated form of mechano growth factor (MGF), a synthetic 24-amino-acid peptide matching the end of one form of the insulin-like growth factor 1 precursor; pegylation attaches polyethylene glycol chains to it.1,2 FDA states that it has not identified any human exposure data for PEG-MGF and that it may pose a significant risk of immune reactions. A 2010 review notes that no natural MGF peptide has been found in the body.2,4 No FDA approval is reported in the sources reviewed here, and PEG-MGF is not among the six peptides in HHS’s October 2026 draft enforcement-discretion policy.2,6
| What it is | Mechano growth factor, a 24-amino-acid peptide also recorded as the IGF-1Ec peptide, with polyethylene glycol attached.1,2 |
|---|---|
| FDA status | No FDA approval is reported in the sources reviewed here. FDA’s compounding safety-risk page lists PEG-MGF among withdrawn nominations with safety concerns, and FDA lists MGF among substances nominated for compounding without adequate support.2,3 |
| Human evidence | None. FDA states that it has not identified any human exposure data for products containing PEG-MGF.2 |
| Evidence strength | Animal and lab studies only. The cited sources report no completed human study; the research base consists of animal, cell, or other laboratory work. How this label is assigned |
Mechano growth factor (MGF) is a synthetic peptide of 24 amino acids, which FDA’s substance registry also records as the insulin-like growth factor 1-Ec peptide.1
A 2010 review explains that the name comes from a form of the insulin-like growth factor 1 gene message that rises in muscle after stretch or injury, and that the synthetic peptide copies the last 24 amino acids of the protein it would encode.4
PEG-MGF, mechano growth factor pegylated, is MGF with polyethylene glycol attached, according to FDA’s compounding safety-risk page.2
The research literature listed on this page concerns mechano growth factor (MGF) itself. FDA states that it has identified no human exposure data for PEG-MGF, and the 2010 review discusses only the non-pegylated peptide.2,4
In laboratory studies, synthetic MGF promoted the multiplication and survival of cells, including muscle precursor cells, according to the 2010 review.4
The review states that no matching peptide made by the body has been identified in cells, tissues or body fluids, and it distinguishes the actions of synthetic MGF from any known natural product of the gene.4
FDA states that it has not identified any human exposure data on products containing PEG-MGF by any route, and that it lacks important information on whether it would cause harm if given to people.2
The sources reviewed here describe only laboratory research on the non-pegylated peptide.4
Evidence-strength label: Animal and lab studies only. How this label is assigned
None of the sources reviewed here reports an approval of PEG-MGF by FDA.1,2
FDA’s compounding safety-risk page, current as of April 22, 2026, lists PEG-MGF among bulk substances previously in category 2, for substances that may present significant safety risks, whose nominations were withdrawn. It cites a possible significant risk of immune reactions and complexities with impurities and characterization.2
FDA’s list of substances nominated for pharmacy compounding, updated May 14, 2026, places mechano growth factor (MGF) in category 3, substances nominated without adequate support.3
HHS’s October 30, 2026 draft enforcement-discretion policy lists six peptides in its Appendix A: BPC-157, Epitalon, KPV, MOTS-c, Semax and TB-500. PEG-MGF is not among them.5,6
Whether it has any effect in people, and whether it is safe: FDA has not identified any human exposure data.2
Whether MGF exists as a natural peptide in the body at all, which the 2010 review describes as unproven.4
PeptideScanner reports what the cited sources say. It is not medical advice and does not recommend using, buying or dosing any substance. Read the full disclaimer.
Go deeper
Everything PeptideScanner has collected for PEG-MGF: reviews, official-source readings, registry and literature records, and every change to this profile.
What the trial and literature lists cover. The trials and papers listed for PEG-MGF are a bounded selection, not every registration or paper about PEG-MGF. For the years before PEG-MGF was added, PeptideScanner took at most 25 ClinicalTrials.gov registrations that list PEG-MGF as an intervention: trials with posted results first, then later-phase trials, then the most recently updated. It also took at most 25 PubMed papers that name PEG-MGF in the title: randomized controlled trials, clinical trials, meta-analyses, systematic reviews and reviews first, then the most recent. Records that also named another tracked peptide, or that failed the publication checks, were left out. A daily check adds newly updated registrations and newly indexed papers that pass the same checks. How records are selected.
Evidence summary
No FDA approval reported; FDA has no human exposure data for it. Evidence is limited to laboratory studies of the non-pegylated peptide, mechano growth factor; the papers listed for this profile concern that peptide. FDA lists PEG-MGF on its compounding safety-risk page among withdrawn nominations. PEG-MGF is not among the six peptides in HHS’s October 2026 draft policy.↗↗↗↗
Status sources checked through November 14, 2026. See status sources and coverage →
Explore this profile’s cited source records →
An editorial human-evidence summary has not yet been published.
Living status brief
No FDA approval reported; FDA has no human exposure data for it. Evidence is limited to laboratory studies of the non-pegylated peptide, mechano growth factor; the papers listed for this profile concern that peptide. FDA lists PEG-MGF on its compounding safety-risk page among withdrawn nominations. PEG-MGF is not among the six peptides in HHS’s October 2026 draft policy.↗↗↗↗
The cited status sources were checked through November 14, 2026. This answer changes only through the profile’s visible version and correction history.
These are counts in PeptideScanner’s selected public collection, not measures of research quality, medical relevance, safety, or effectiveness.
Literature metadata · source date November 9, 2026
Producing human mechano growth factor (MGF) in Escherichia coli.↗Added to PeptideScanner November 16, 2026Literature metadata · added November 16, 2026
Producing human mechano growth factor (MGF) in Escherichia coli.↗Source date November 9, 2026Literature metadata · added November 16, 2026
The role of mechano growth factor in chondrocytes and cartilage defects: a concise review.↗Source date September 21, 2024Literature metadata · added November 16, 2026
Mechano-Growth Factor: an important cog or a loose screw in the repair machinery?↗Source date March 21, 2024PeptideScanner currently has no selected clinical trial records, regulatory records, and safety records connected to this profile. That is a collection gap, not evidence that no such records exist.
PeptideScanner does not infer an answer where the cited records do not provide one. Open the source-linked records below to inspect their scope and limits.
Evidence Map v1
This map describes PeptideScanner’s selected, source-linked collection. It is not an evidence grade and does not establish research quality, safety, effectiveness, or medical relevance.
0 of 0 selected trial records include at least one phase value; 0 of 0 include a status value in the retained structured contract.
20 of 20 selected PubMed records include attributed title, venue, publication date, and publication-type fields.
Application counts reflect exact reviewed ingredient connections; Federal Register counts reflect exact reviewed peptide-name matches; DailyMed counts reflect listed SPL versions with retained ZIP receipts. “Published” describes this page’s indexing surface, not the state of scientific evidence.
Research hub
PeptideScanner change dates and cited source dates stay separate. These entries report collection or version activity, not a ranking of importance.
PubMed lists PMID 16408771 in Sheng li ke xue jin zhan [Progress in physiology] as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2005-10 (month precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PubMed lists PMID 17044786 in Hybridoma (2005) as Journal Article, with publication-date metadata of 2006-10 (month precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PubMed lists PMID 17156777 in Experimental cell research as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2006-11-07 (day precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
20 with attributed title, venue, publication-date, and type metadata.
Selected records span April 9, 2008 to November 9, 2026. These dates come from selected source records and PubMed metadata, not a complete or continuous timeline of research, safety, approval, or effectiveness.
These links are based only on overlapping years and evidence lanes in PeptideScanner’s selected records. They do not imply that the peptides are medically or scientifically similar.
Literature metadata
PubMed lists PMID 18068377 in Protein expression and purification as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-11-07 (day precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 37171185 in Acta biochimica et biophysica Sinica as Review, Journal Article, with publication-date metadata of 2023-05-12 (day precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 23125840 in Frontiers in endocrinology as Journal Article, with publication-date metadata of 2012-11-01 (day precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 20130113 in Endocrinology as Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S., Review, with publication-date metadata of 2010-02-03 (day precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 18837392 in Sheng wu gong cheng xue bao = Chinese journal of biotechnology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2008-07 (month precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 22328223 in Rapid communications in mass spectrometry : RCM as Journal Article, with publication-date metadata of 2012-03-30 (day precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 30952709 in Anticancer research as Journal Article, with publication-date metadata of 2019-04 (month precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 25588515 in BMC biochemistry as Journal Article, with publication-date metadata of 2015-01-15 (day precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 27040239 in Materials science & engineering. C, Materials for biological applications as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2016-02-27 (day precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 22382131 in Acta biochimica et biophysica Sinica as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2012-03-01 (day precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 19911128 in Science in China. Series C, Life sciences as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2009-11-13 (day precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 25345350 in Biotechnology and applied biochemistry as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-08-06 (day precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Citations
Numbered markers in the text point here. Each link opens the original public record.
FDA Global Substance Registration System · Official source · Source checked November 16, 2026
U.S. Food and Drug Administration · Official source · Source checked November 14, 2026
U.S. Food and Drug Administration · Official source · Source checked November 16, 2026
Endocrinology · Official source · Source checked November 16, 2026
Federal Register · U.S. Department of Health and Human Services · Official source · Source checked November 14, 2026
U.S. Department of Health and Human Services · Official source · Source checked November 14, 2026